These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28392495)

  • 1. Cocrystal solubility product analysis - Dual concentration-pH mass action model not dependent on explicit solubility equations.
    Avdeef A
    Eur J Pharm Sci; 2017 Dec; 110():2-18. PubMed ID: 28392495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
    Li Z; Matzger AJ
    Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
    Alhalaweh A; Roy L; Rodríguez-Hornedo N; Velaga SP
    Mol Pharm; 2012 Sep; 9(9):2605-12. PubMed ID: 22867056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamic Solubility Profile of Carbamazepine-Cinnamic Acid Cocrystal at Different pH.
    Keramatnia F; Shayanfar A; Jouyban A
    J Pharm Sci; 2015 Aug; 104(8):2559-65. PubMed ID: 26096952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocrystal Solubility Product Prediction Using an in combo Model and Simulations to Improve Design of Experiments.
    Avdeef A
    Pharm Res; 2018 Feb; 35(2):40. PubMed ID: 29396647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic Analysis of Cocrystal Dissolution as a Function of pH and Micellar Solubilization.
    Cao F; Amidon GL; Rodriguez-Hornedo N; Amidon GE
    Mol Pharm; 2016 Mar; 13(3):1030-46. PubMed ID: 26877267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
    Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
    Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Basis of Cocrystal Dissolution Advantage.
    Cao F; Amidon GL; Rodríguez-Hornedo N; Amidon GE
    J Pharm Sci; 2018 Jan; 107(1):380-389. PubMed ID: 28989017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering cocrystal solubility, stability, and pH(max) by micellar solubilization.
    Huang N; Rodríguez-Hornedo N
    J Pharm Sci; 2011 Dec; 100(12):5219-34. PubMed ID: 21910122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer.
    Yamashita H; Sun CC
    Pharm Res; 2017 Dec; 35(1):4. PubMed ID: 29288433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Poor Solubility of a Salt-Cocrystal Hydrate: A Case Study of the Common-Ion Effect in Betrixaban, an Anticoagulant Drug.
    Devarapalli R; Indukuri A; Bollineni M; Mondal A; Reddy CM; Chennuru R
    Mol Pharm; 2021 Mar; 18(3):1138-1149. PubMed ID: 33528261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms by which moisture generates cocrystals.
    Jayasankar A; Good DJ; Rodríguez-Hornedo N
    Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-Scale Assays for Studying Dissolution of Pharmaceutical Cocrystals for Oral Administration.
    Box KJ; Comer J; Taylor R; Karki S; Ruiz R; Price R; Fotaki N
    AAPS PharmSciTech; 2016 Apr; 17(2):245-51. PubMed ID: 26208438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
    Rahman Z; Samy R; Sayeed VA; Khan MA
    Pharm Dev Technol; 2012; 17(4):457-65. PubMed ID: 21265708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
    Basavoju S; Boström D; Velaga SP
    Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hansen solubility parameter as a tool to predict cocrystal formation.
    Mohammad MA; Alhalaweh A; Velaga SP
    Int J Pharm; 2011 Apr; 407(1-2):63-71. PubMed ID: 21256944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals.
    Ren S; Liu M; Hong C; Li G; Sun J; Wang J; Zhang L; Xie Y
    Acta Pharm Sin B; 2019 Jan; 9(1):59-73. PubMed ID: 30766778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical Cocrystal: An Antique and Multifaceted Approach.
    Panzade PS; Shendarkar GR
    Curr Drug Deliv; 2017; 14(8):1097-1105. PubMed ID: 27758692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How cocrystals of weakly basic drugs and acidic coformers might modulate solubility and stability.
    Kuminek G; Rodríguez-Hornedo N; Siedler S; Rocha HV; Cuffini SL; Cardoso SG
    Chem Commun (Camb); 2016 Apr; 52(34):5832-5. PubMed ID: 27042997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.